• Corpus ID: 21769227

Comparative Proteomics of Tumor and Paired Normal Breast Tissue Highlights Potential Biomarkers in Breast Cancer.

  title={Comparative Proteomics of Tumor and Paired Normal Breast Tissue Highlights Potential Biomarkers in Breast Cancer.},
  author={Gustavo G{\'o}es Da Costa and Talita Helen Bombardelli Gomig and Rodrigo Kaviski and Karla Santos Sousa and Caroline Kukolj and Rubens Silveira de Lima and C{\'i}cero de Andrade Urban and Iglenir Jo{\~a}o Cavalli and Enilze Maria de Souza Fonseca Ribeiro},
  journal={Cancer genomics \& proteomics},
  volume={12 5},
BACKGROUND/AIM Breast cancer is the most common type of cancer among women worldwide, and about 57,000 new cases are expected for the Brazilian population in 2015. Elucidation of protein expression and modification is essential for the biological understanding, early diagnosis and therapeutics of breast cancer. The main objectives of the study are comparison between the proteome of tumor and paired non-tumor breast cancer tissues, describing all identified proteins, highlighting the ones most… 

Figures and Tables from this paper

Proteomic Analysis of Primary Colon Cancer and Synchronous Solitary Liver Metastasis

These differentially expressed proteins (DEPs) can potentially be used as biomarkers for the diagnosis of liver metastasis and they may provide a new strategy for developing anti-metastatic liver drugs in colon cancer patients.

Early diagnosis of colorectal cancer via plasma proteomic analysis of CRC and advanced adenomatous polyp

FGB and C4A can be considered as plasma potential biomarkers to early diagnosis of CRC patients and understanding the underlying procedures in tumorigenesis to demonstrate that plasma proteins can be less invasive markers for the detection of CRC.

Lipidomics investigations into the tissue phospholipidomic landscape of invasive ductal carcinoma of the breast

The need of identifying alternative therapeutic targets for invasive ductal carcinoma (IDC) of the breast with high specificity and sensitivity for effective therapeutic intervention is crucial for

Downregulated Expression of Tropomyosin 1 in Intrahepatic Cholangiocarcinoma: A Predictor of Recurrence and Prognosis

  • Yan ChenZhixian Hong Yinying Lu
  • Medicine
    Medical science monitor : international medical journal of experimental and clinical research
  • 2018
TPM1 may serve as a useful biomarker for predicting tumor recurrence and prognosis in patients with ICC and multivariate analysis showed that TPM1 could be a potential biomarkers for predicting the recurrence of ICC.

Pediatric Ependymoma: A Proteomics Perspective.

Through the proposed nanoLC-MS/MS method, a large number of similarities regarding proteome content are revealed compared to other two pediatric brain tumor entities; astrocytomas and medulloblastomas.

Differential Intracellular Protein Distribution in Cancer and Normal Cells—Beta-Catenin and CapG in Gynecologic Malignancies

Simple Summary The distribution and mobility of proteins inside the living cell can be used to differentiate cancer from normal cells. This review highlights differential protein distribution of two

Graph-theoretical comparison of normal and tumor networks in identifying BRCA genes

A framework for the comparative graph-theoretical analysis of networks integrating the relevant gene expression, mutations, and potein-protein interaction network data and shows that a betweenness-based measure differentiates BRCA genes across all normal versus tumor network pairs, than the rest of the popular centrality-based measures.

Function of the macrophage-capping protein in colorectal carcinoma.

CapG was overexpressed in CRC and was associated with tumor progression; therefore, it may be a useful prognostic biomarker and therapeutic target in CRC.



Proteomic analysis of non-tumoral breast tissue.

Breast cancer is a complex and heterogeneous disease. In spite of the advances made in recent decades, a better understanding of the intrinsic mechanisms of this disease is crucial. The development

Comparative proteome analysis of breast cancer and normal breast

Two-dimensional gel electrophoresis combined with mass spectrometry was used to analyze changes in the proteome of infiltrating ductal carcinoma compared to normal breast tissue, and proteomics offers a powerful methodology to detect the proteins that show different expression patterns in breast cancer tissue and may provide an accurate molecular classification.

Comparative proteomics of primary breast carcinomas and lymph node metastases outlining markers of tumor invasion.

Comparing the proteome profile of primary breast tumors against that of lymph node metastasis strengthens previous omics-based studies and support the validation of potential markers of tumor invasion and metastasis.

The Differential Expression of Aqueous Soluble Proteins in Breast Normal and Cancerous Tissues in Relation to Stage and Grade of Patients

A significant relationship between the expression of the proteins with the stage or grade of IDC can be established, which increases the usefulness of these proteins as biomarkers for IDC.

Comparative proteomic analysis of ductal breast carcinoma demonstrates an altered expression of chaperonins and cytoskeletal proteins.

The proteins which the authors observed to exhibit an altered expression in infiltrating ductal breast carcinoma may be exploited as novel targets for therapeutic interventions or represent novel diagnostic/prognostic markers for the early detection of aggressive tumors, particularly those with multridrug-resistant phenotypes during the earlier stages of the disease.

Proteomic analysis in human breast cancer: Identification of a characteristic protein expression profile of malignant breast epithelium

A proteomic analysis of matched normal and malignant epithelia from invasive breast carcinomas leads to a better understanding of oncogenesis at an operational level and helps to characterize the malignant phenotype of individual tumors, and thereby to identify novel targets for antineoplastic therapy.

Serum proteome profiling of primary breast cancer indicates a specific biomarker profile.

14 biomarkers whose combination detects breast cancer patients from non-cancer controls with a sensitivity of 89% and specificity of 67%.

Quantitative proteomic profiling of matched normal and tumor breast tissues.

Proteomic analysis of breast cancer tissue has proven difficult due to its inherent histological complexity. This pilot study presents preliminary evidence for the ability to differentiate adenoma

Proteomics of human breast ductal carcinoma in situ.

Proteomic analysis of DCIS revealed differential expression patterns distinct from previous nucleic acid-based studies and identified new facets of the earliest stage of breast cancer progression.

Proteomic analysis of tissue samples in translational breast cancer research

This work critically appraises what has been achieved to date using proteomic technologies and brings forward novel strategies – based on the analysis of clinically relevant samples – that promise to accelerate the translation of basic discoveries into the daily breast cancer clinical practice.